PulseAugur
LIVE 04:16:35
commentary · [1 source] ·
0
commentary

CDC acting director criticizes vaccine study methodology

Jay Bhattacharya, the acting director of the CDC, has reportedly blocked the publication of a study on COVID-19 vaccine effectiveness due to its methodology. The study, which used the test-negative design, indicated that the season's vaccines were about half as effective at preventing hospitalizations in healthy adults. Bhattacharya criticized the study's design as "crap" and "logistically ridiculous," though the test-negative design has been a standard method for estimating vaccine effectiveness for two decades. AI

Summary written by gemini-2.5-flash-lite from 1 source. How we write summaries →

RANK_REASON Article discusses a controversy surrounding a public health official's critique of a study's methodology, rather than a new release or core research finding.

Read on Forbes — Innovation →

CDC acting director criticizes vaccine study methodology

COVERAGE [1]

  1. Forbes — Innovation TIER_1 · John Drake, Contributor ·

    Acting CDC Director Jay Bhattacharya Called A Vaccine Study Design 'Crap.' What The Test-Negative Design Is And How We Know Whether Vaccines Measured With It Are Effective

    Jay Bhattacharya dismissed the test-negative design as 'crap.' The biostatistics literature tells a different story.